Our analytical R&D team engages in stability and degradation studies on APIs and other drugs. The team supports all stages of pharmaceutical development including, among others, (i) providing method development and validation services for a wide range of analytical technologies, (ii) preparing complete specifications for raw materials, APIs, finished products, intermediates and excipients, (iii) conducting in-house tests for strict control of pharmacopeial materials and products, (iv) conducting stability studies of APIs and formulations in accordance with applicable guidelines, and (v) analyzing active ingredients and key raw materials.